Literature DB >> 32019480

Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China.

Yuesong Pan1,2, Lei Zhang1,2,3, Zixiao Li1,2, Xia Meng1,2, Yilong Wang1,2, Hao Li1,2, Liping Liu1,2, Yongjun Wang1,2.   

Abstract

Background and Purpose- Multifaceted quality improvement interventions of stroke care have been shown to improve hospital personnel adherence to evidence-based performance measures and subsequent stroke outcomes. This study aimed to evaluate the cost-effectiveness of a multifaceted quality improvement intervention for stroke care in China, the world's largest low- and middle-income country. Methods- A short-term decision tree model and a long-term Markov model were used to analyze the cost-effectiveness of a multifaceted quality improvement intervention for patients with acute ischemic stroke. Outcomes, transition probability, and cost data were obtained from a recent clinical trial and the published literature. The benefit of the intervention was assessed by the costs per quality-adjusted life-years gained in the short- and long-term. One-way and probabilistic sensitivity analyses were performed to assess the uncertainty of the findings. Results- Compared with usual care, a multifaceted quality improvement intervention for stroke care was found to be cost-effective in the first year and highly cost-effective from the second year onward. In the long-term, the intervention yielded a lifetime gain of 0.246 quality-adjusted life-years at an additional cost of Chinese Yuan Renminbi 1510 (US $230), resulting in a cost of Chinese Yuan Renminbi 6138 (US $940) per quality-adjusted life-year gained. Probabilistic sensitivity analysis indicated that the intervention was highly cost-effective in 99.9% of the simulation runs at a willingness-to-pay threshold of Chinese Yuan Renminbi 59 700 (1× gross domestic product per capita of China in 2017, US $9200) per quality-adjusted life-year. Conclusions- A multifaceted quality improvement intervention for stroke care was highly cost-effective in China. The results of this study may be used as a reference for delivering such interventions in low- and middle-income countries and in underserved areas of high-income countries.

Entities:  

Keywords:  gross domestic product; quality improvement; quality of care; quality-adjusted life-year; uncertainty

Mesh:

Year:  2020        PMID: 32019480     DOI: 10.1161/STROKEAHA.119.027980

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

1.  Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack.

Authors:  Jigang Chen; Linjin Ji; Xin Tong; Mingyang Han; Songfeng Zhao; Yongkai Qin; Zilong He; Zhiqun Jiang; Aihua Liu
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

2.  Cost-effective analysis of mechanical thrombectomy alone in the treatment of acute ischaemic stroke: a Markov modelling study.

Authors:  Mingyang Han; Yongkai Qin; Xin Tong; Linjin Ji; Songfeng Zhao; Lang Liu; Jigang Chen; Aihua Liu
Journal:  BMJ Open       Date:  2022-04-06       Impact factor: 2.692

3.  Cost Utility Analysis of Multidisciplinary Postacute Care for Stroke: A Prospective Six-Hospital Cohort Study.

Authors:  Yu-Ching Chen; Yu-Jo Yeh; Chung-Yuan Wang; Hsiu-Fen Lin; Ching-Huang Lin; Hong-Hsi Hsien; Kuo-Wei Hung; Jung-Der Wang; Hon-Yi Shi
Journal:  Front Cardiovasc Med       Date:  2022-03-30

4.  Long-Term Effect of Left Atrial Appendage Occlusion in Treating Patients with Previous Ischemic Stroke on the Disease Recurrence.

Authors:  Jia Yu; Yufeng Liu; Peng Sun; Xing Guo; Haiyang Jiang; Wei Fang; Xin Jin
Journal:  Comput Math Methods Med       Date:  2021-10-13       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.